上海新世界股份有限公司 关于召开 2022 年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 证券代码：600628 证券简称：新世界 公告编号：临 2023-023 重要内容提示： 会议召开时间：2023 年 6 月 9 日（星期五）下午 15:00-16:00 会 议 召 开 地 点 ： 上 海 证 券 报 · 中 国 证 券 网 （ 网 址 ： https://roadshow.cnstock.com/） 会议召开方式：视频录播结合网络文字互动 投资者可于 2023 年 6 月 8 日（星期四）下午 16:00 前将有关问题通过电 子邮件的形式发送至公司董事会办公室邮箱 xsj600628@163.com，公司将在 2022 年度业绩说明会上对投资者普遍关注的问题进行回答。 上海新世界股份有限公司（以下简称"公司"）已于 2023 年 4 月 13 日 在上海证券交易所网站（http://www.sse.com.cn）披露了《公司 2022 年 年度报告》，为便于广大投资者更全面深入地了解公司 202 ...

证券代码：600628 证券简称：新世界 公告编号：临2023-022 上海新世界股份有限公司 关于举办"走进上市公司"投资者交流活动情况的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 上海新世界股份有限公司（以下简称"公司"）于 2023 年 5 月 29 日下午举办了"走 进上市公司"投资者交流活动。本次活动旨在加强公司与投资者的沟通交流，让更多的投 资者近距离了解公司，增进上市公司市场认同和价值实现，提高上市公司质量。 现将本次活动的主要情况公告如下： 一、交流活动基本情况 时间：2023 年 5 月 29 日下午 2:00 形式：现场接待 调研机构：申万宏源证券 接待人：公司董事长陈湧先生，副董事长、总经理沈为民先生，副总经理、董事会秘 书、财务总监王文华女士，新世界城副总经理、品牌招商部经理李蔚先生，董办等相关人 员 二、交流活动的主要问题及回复 1、想请教公司酒店板块和零售板块整体回暖情况如何，针对接下来的零售业态有无 一些战略打法上的调整？ 答：2023 年春节之后，随着整体经济运行回暖向好的积极态势，顾 ...

Financial Performance - The company's operating revenue for Q1 2023 was ¥264,600,085.39, representing a year-on-year increase of 26.12%[4] - The net profit attributable to shareholders for the same period was ¥23,908,709.70, showing a significant increase of 127.82% compared to the previous year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses reached ¥16,248,978.83, with a remarkable growth of 439.94%[4] - Basic and diluted earnings per share were both ¥0.04, reflecting a 100% increase compared to the same period last year[4] - Operating profit for Q1 2023 was ¥26,257,891.36, significantly up from ¥3,139,373.28 in Q1 2022, marking an increase of 736.5%[14] - Net profit for Q1 2023 was ¥24,051,209.70, compared to ¥10,589,789.99 in Q1 2022, representing an increase of 127.5%[14] - The total comprehensive income for Q1 2023 was ¥24,767,756.35, compared to ¥8,576,859.80 in Q1 2022, an increase of 189.5%[14] Cash Flow - The net cash flow from operating activities was -¥13,743,271.34, indicating a decline of 67.76% year-on-year[4] - In Q1 2023, the cash inflow from operating activities was CNY 311,264,279.75, an increase of 14.94% compared to CNY 270,769,924.64 in Q1 2022[16] - The net cash flow from operating activities was -CNY 13,743,271.34, an improvement from -CNY 42,623,752.45 in the same period last year[16] - The cash inflow from investment activities totaled CNY 1,146,584,879.44, up from CNY 1,054,399,517.81 in Q1 2022, marking an increase of 8.73%[16] - The net cash flow from investment activities was CNY 417,829,348.76, significantly higher than CNY 13,981,266.81 in Q1 2022[16] - The cash inflow from financing activities was CNY 250,000,000.00, down from CNY 300,000,000.00 in Q1 2022, a decrease of 16.67%[16] - The net cash flow from financing activities was -CNY 54,464,714.62, worsening from -CNY 7,671,865.81 in the previous year[16] Assets and Liabilities - Total assets at the end of the reporting period were ¥5,657,644,378.82, a decrease of 1.01% from the end of the previous year[4] - Total liabilities decreased to ¥1,421,417,804.76 in Q1 2023 from ¥1,504,018,868.42 in Q1 2022, a reduction of 5.5%[12] - Current liabilities totaled ¥1,393,670,052.42 in Q1 2023, down from ¥1,475,749,786.99 in Q1 2022, reflecting a decrease of 5.6%[12] - The total non-current assets were RMB 3,518,923,568.23, a slight decrease from RMB 3,526,145,646.18[11] - The total assets of the company as of March 31, 2023, were RMB 5,657,644,378.82, down from RMB 5,715,539,279.37[11] Shareholder Information - The top shareholder, Shanghai Huangpu District State-owned Assets Supervision and Administration Commission, holds 20.73% of the shares, totaling 134,074,446 shares[9] - Shanghai Zongyi Holdings Co., Ltd. is the second-largest shareholder with 13.07% ownership, amounting to 84,524,934 shares[9] Other Financial Metrics - The weighted average return on equity rose by 0.33 percentage points to 0.57%[4] - The company reported a significant reduction in trading financial assets, which decreased to RMB 157,500,000.00 from RMB 592,000,000.00[11] - The inventory decreased to RMB 144,248,825.30 from RMB 161,074,560.04, reflecting a decline of approximately 10.4%[11] - The company reported a decrease in financial expenses to ¥3,539,261.93 in Q1 2023 from ¥7,552,361.23 in Q1 2022, a reduction of 53.1%[14] - Other income for Q1 2023 was ¥96,720.63, down from ¥140,992.07 in Q1 2022, a decrease of 31.4%[14] Strategic Outlook - The company has not disclosed any significant new strategies or future outlook in the provided documents[10]

Financial Performance - The company's operating revenue for 2022 was ¥850.02 million, a decrease of 27.07% compared to ¥1,165.55 million in 2021[20]. - The net profit attributable to shareholders for 2022 was -¥52.02 million, representing a decline of 174.90% from a profit of ¥69.46 million in 2021[20]. - The net cash flow from operating activities was ¥22.78 million, down 91.23% from ¥259.75 million in the previous year[20]. - The total assets at the end of 2022 were ¥5.72 billion, a decrease of 6.47% from ¥6.11 billion at the end of 2021[20]. - The company reported a basic earnings per share of -¥0.08 for 2022, a decrease of 172.73% from ¥0.11 in 2021[21]. - The weighted average return on equity was -1.21% for 2022, down 2.81 percentage points from 1.60% in 2021[21]. - The company reported a total profit of -59.57 million yuan, a decline of 152.47% compared to the previous year[55]. - The gross profit margin for department store joint sales was 47.78%, down from 67.91% in the previous year[47]. - The gross profit margin for self-operated pharmaceutical sales was 33.67%, compared to 27.78% in 2021[48]. - The company reported a net profit margin of 8% for 2022, with a goal to improve this to 10% in the next fiscal year[103]. Revenue Breakdown - The operating revenue from department stores was 212.93 million yuan, down 36.50% year-on-year[54]. - The pharmaceutical sales revenue reached 525.92 million yuan, while hotel services revenue was 47.85 million yuan, reflecting decreases of 16.76% and 48.32% respectively[54]. - Total revenue from Shanghai decreased by 27.03% to ¥835,704,543.42, with a gross margin reduction of 10.28 percentage points to 26.84%[60]. - The company achieved total operating revenue of 850.02 million yuan in 2022, a decrease of 27.07% compared to the previous year[54]. - The company’s total revenue for 2022 was CNY 850 million, with department store revenue at CNY 213 million and pharmaceutical revenue at CNY 526 million, together accounting for 86.92% of total revenue[166]. Cash Flow and Investments - The net cash flow from operating activities was 22.78 million yuan, a significant drop of 91.23% year-on-year[57]. - The company's cash flow from investment activities increased by 157.80% to ¥372,256,936.85, driven by higher cash inflows from redemptions exceeding purchases[65]. - The company reported a net cash outflow from financing activities of -¥265,697,320.45, a 142.19% increase in outflow due to debt repayment[65]. - The cash flow from investing activities showed a net inflow of CNY 372,256,936.85, a recovery from a net outflow of CNY 644,080,176.21 in 2021[190]. - The total cash inflow from investment activities in 2022 was 5,199,732,361.89 RMB, compared to 4,214,939,109.21 RMB in 2021, resulting in a net cash flow of 400,673,455.02 RMB[192]. Market Challenges and Strategies - The company faced significant challenges in the Shanghai consumer market, leading to a substantial decline in customer traffic and sales[22]. - The company expanded marketing efforts and introduced new brands to improve performance, but faced additional operational challenges in December 2022[22]. - The overall economic environment in China showed a GDP growth of 3% in 2022, with retail sales declining by 0.2%, impacting the company's performance[28]. - The company is addressing challenges in the retail sector, including declining sales and changing consumer habits, by adapting its strategies accordingly[85]. - Increased market competition and policy changes in the retail sector are anticipated to further pressure the company's sales performance[93]. Social Responsibility and Employee Welfare - The company implemented a rent reduction policy, providing over ¥40 million in rent relief to small and micro enterprises and individual businesses[22]. - The company actively engaged in social responsibility initiatives, including providing support for pandemic-related efforts and implementing rent reductions for small businesses[32]. - The company increased employee benefits, including meal subsidies and additional health check-up items, to improve employee welfare and engagement[37]. - Total investment in social responsibility projects amounted to 2.481 million RMB, with 1.781 million RMB in cash donations and 700,000 RMB in material donations[129]. Corporate Governance and Shareholder Engagement - The company has maintained compliance with legal and regulatory requirements regarding corporate governance, ensuring transparency in information disclosure[102]. - The board of directors and supervisory board consist of qualified members, with a focus on maintaining independence and avoiding conflicts of interest[102]. - The company has established measures to balance the expectations of stakeholders, including shareholders, customers, and employees, to promote sustainable development[102]. - The total compensation for senior management during the reporting period amounted to 459.24 million yuan, with the highest individual compensation being 75 million yuan[102]. - The company has not faced any penalties from securities regulatory authorities in the past three years[107]. Future Outlook and Strategic Initiatives - The company aims to enhance its position in the Shanghai international consumer center and maintain its leadership in the Nanjing Road commercial area[83]. - The health consumption market is experiencing accelerated growth, driven by increased health awareness and supportive government policies, creating new economic growth points[80]. - The company plans to focus on the transformation of department store formats and the integration of consumption and experience in 2023[84]. - The company is investing heavily in R&D, allocating 500 million RMB for the development of new technologies and products in the upcoming year[104]. - Future outlook indicates a projected revenue growth of 12% for 2023, driven by new product launches and market expansion strategies[104].

上海新世界股份有限公司（600628）2022 年第三季度报告 证券代码：600628 证券简称：新世界 上海新世界股份有限公司 2022 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚假记载、 误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息的真实、准 确、完整。 第三季度财务报表是否经审计 □是 √否 一、 主要财务数据 主要会计数据和财务指标 | | | | | 单位：元 币种：人民币 | | --- | --- | --- | --- | --- | | 项目 | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末比上年 | | | | 增减变动幅度(%) | | 同期增减变动幅度(%) | | 营业收入 | 247,599,865.81 | -12.49 | 581,437,386.21 ...

上海新世界股份有限公司（600628）2022 年第一季度报告 证券代码：600628 证券简称：新世界 上海新世界股份有限公司 2022 年第一季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚假记载、 误导性陈述或重大遗漏，并承担个别和连带的法律责任。 单位：元 币种：人民币 | 项目 | 本报告期 | | 本报告期比上年同期增减变动幅度(%) | | --- | --- | --- | --- | | 营业收入 | | 209,797,726.05 | -22.13 | | 归属于上市公司股东的净利润 | | 10,494,789.99 | -55.71 | | 归属于上市公司股东的扣除非经常性 损益的净利润 | | -4,779,913.45 | -120.90 | | 经营活动产生的现金流量净额 | | -42,623,752.45 | 41.39 | | 基本每股收益（元/股） | | 0.02 | ...

上海新世界股份有限公司（600628）2021 年年度报告 公司代码：600628 公司简称：新世界 经本次公司董事会审议通过的利润分配预案为：以2021年末总股本为基数，每10股派送红利0.55元(含 税)；本次不进行资本公积金转增股本。此预案，须经2021年度股东大会审议通过。 六、 前瞻性陈述的风险声明 √适用 □不适用 本年度报告涉及未来计划、发展战略等前瞻性陈述，该等陈述不构成对投资者的实质承诺，请投资者 注意投资风险。 七、 是否存在被控股股东及其关联方非经营性占用资金情况 上海新世界股份有限公司 2021 年年度报告 1 / 132 上海新世界股份有限公司（600628）2021 年年度报告 重要提示 五、 董事会决议通过的本报告期利润分配预案或公积金转增股本预案 否 八、 是否存在违反规定决策程序对外提供担保的情况 否 九、 是否存在半数以上董事无法保证公司所披露年度报告的真实性、准确性和完整性 否 十、 重大风险提示 公司已在本报告中描述可能存在的相关风险，敬请投资者查阅第三节管理层讨论与分析中关于公司未 来发展的讨论与分析中可能面对的风险内容。 十一、 其他 □适用 √不适用 2 / 13 ...

上海新世界股份有限公司（600628）2021 年第三季度报告 第三季度财务报表是否经审计 □是 √否 一、 主要财务数据 主要会计数据和财务指标 注:"本报告期"指本季度初至本季度末 3 个月期间，下同。 证券代码：600628 证券简称：新世界 上海新世界股份有限公司 2021 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚假记载、 误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务报表信息的真实、 准确、完整。 单位：元 币种：人民币 项目 本报告期 本报告期比上年同期 增减变动幅度(%) 年初至报告期末 年初至报告期末比上年 同期增减变动幅度(%) 营业收入 282,949,876.94 0.78 844,046,131.28 17.29 归属于上市公司股东的净利润 19,507,701.71 4.34 81,1 ...

上海新世界股份有限公司（600628）2021 年半年度报告 公司代码：600628 公司简称：新世界 上海新世界股份有限公司 2021 年半年度报告 1 / 97 上海新世界股份有限公司（600628）2021 年半年度报告 重要提示 无 六、 前瞻性陈述的风险声明 √适用 □不适用 本半年度报告涉及未来计划等前瞻性陈述，该等陈述不构成公司对投资者的实质承诺，请投资者注意投 资风险。 七、 是否存在被控股股东及其关联方非经营性占用资金情况 否 八、 是否存在违反规定决策程序对外提供担保的情况？ 否 九、 是否存在半数以上董事无法保证公司所披露半年度报告的真实性、准确性和完整性 否 十、 重大风险提示 公司已在本报告中描述可能存在的相关风险，敬请投资者查阅第三节管理层讨论与分析中其他披露事项 中可能面对的风险内容。 十一、 其他 □适用 √不适用 2 / 97 一、 本公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、 公司全体董事出席董事会会议。 三、 本半年度报告未经审计。 四、 公司负责人董事长徐若 ...

上海新世界股份有限公司（600628）2021 年第一季度报告 公司代码：600628 公司简称：新世界 上海新世界股份有限公司 二、 公司基本情况 2021 年第一季度报告 1 / 21 | | | | 一、 重要提示 3 | | --- | | 二、 公司基本情况 3 | | 三、 重要事项 5 | | 四、 附录 9 | 上海新世界股份有限公司（600628）2021 年第一季度报告 一、 重要提示 1.1 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚假 记载、误导性陈述或者重大遗漏，并承担个别和连带的法律责任。 1.2 公司全体董事出席董事会审议季度报告。 1.3 公司负责人董事长徐若海先生，副董事长、总经理徐家平先生、主管会计工作负责人财务总监王文华女 士及会计机构负责人（会计主管人员）财务部经理周平先生保证季度报告中财务报表的真实、准确、完 整。 1.4 本公司第一季度报告未经审计。 2.1 主要财务数据 说明： 本期归属于上市公司股东的净利润比上年同期增加 270.20%，主要系去年公司百货零售业、酒店服务业受新 冠疫情影响较大，今年百货零售业、医药销 ...